evaluate the supplements company replenza on semaglutide Launches GLP-1 Support Products Novo cuts GLP-1 prices 70%,

According to the GIC, 1/3 of the FY26 premium increase is directly attributable to GLP-1 coverage for weight loss

GLP-1RAs have also been shown to attenuate vascular inflammation and oxidative stress, while preserving endothelial barrier integrity and limiting neutrophil infiltration in models of sepsis-associated acute lung injury (ALI) (Helmstadter et al., 2021

In a study comparing the effects of semaglutide and tirzepatide for weight loss, those receiving tirzepatide were more likely to achieve 5% or greater, 10% or greater, and 15% or greater weight loss and experienced larger reductions in body weight at 3, 6, and 12 months

Moreover, SEM has been shown to lower systolic blood pressure, protect renal function, improve insulin resistance, and induce anti-obesity effects [14,32]

Endocrinology 2008

[DOI] [PMC free article] [PubMed] [Google Scholar] Koole C, Pabreja K, Savage EE, Wootten D, Furness SG, Miller LJ, Christopoulos A, Sexton PM